Clinical Trial Update: A Study on the Use of Tanakan® for Recovery of Neurological Impairment Following Ischaemic Stroke [Phase 3]

View source ↗

Summary

A Phase 3 trial investigating Tanakan for recovery of neurological impairment after acute ischemic stroke has completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurological Impairment
• Stroke

Drugs mentioned

• Tanakan

Snippet

Sponsor: Ipsen | Conditions: Stroke, Acute, Neurological Impairment | Phase 3 | Status: COMPLETED | Results posted: 2018-02-19